Pharmacological Validation of ASIC1a as a Druggable Target for Neuroprotection in Cerebral Ischemia Using an Intravenously Available Small Molecule Inhibitor

por Qi, Xin, Lu, Jian-Fei, Huang, Zi-Yue, Liu, Yi-Jun, Cai, Lu-Bing, Wen, Xin-Lan, Song, Xing-Lei, Xiong, Jian, Sun, Pei-Yi, Zhang, Hao, Zhang, Ting-Ting, Zhao, Xuan, Jiang, Qin, Li, Ying, Krishtal, Oleg, Hou, Leng-Chen, Zhu, Michael X., Xu, Tian-Le
Publicado 2022